Tech Company Financing Transactions

Mozart Therapeutics Funding Round

AbbVie Biotech Ventures, Alexandria Venture Investments and Altitude Life Science Ventures participated in a $25 million Series A venture round for Mozart Therapeutics. This VC investment round was announced on 6/7/2023.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

410 West Harrison St. 150
Seattle, WA 98119
USA

Phone

Undisclosed

Website

www.mozart-tx.com

Email Address

[email protected]

Overview

Mozart Therapeutics is focused on developing disease-modifying therapies for autoimmune and inflammatory diseases that work by targeting a novel regulatory immune pathway. The therapeutic focus of Mozart's lead program is autoimmune mediated gastro-intestinal disorders. The company is headquartered in Seattle, WA.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chairman

Steven Gillis

        

Chief Executive Officer

Katie Fanning

        

Chief Scientific Officer

Kristine Swiderek

        

Vice President

Courtney Crane

        

Browse more venture capital transactions:

Prev: 6/7/2023: Woltair venture capital transaction
Next: 6/7/2023: Instabase venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary